These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21507593)

  • 1. A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma.
    van de Merbel NC; Bronsema KJ; van Hout MW; Nilsson R; Sillén H
    J Pharm Biomed Anal; 2011 Jul; 55(5):1089-95. PubMed ID: 21507593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume.
    Xu Y; Yuan Y; Smith L; Edom R; Weng N; Mamidi R; Silva J; Evans DC; Lim HK
    J Pharm Biomed Anal; 2013 Nov; 85():145-54. PubMed ID: 23948760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of P450 3A4 endogenous biomarker - 4β-hydroxycholesterol - in human plasma using LC/ESI-MS/MS.
    Huang MQ; Lin W; Wang W; Zhang W; Lin ZJ; Weng N
    Biomed Chromatogr; 2014 Jun; 28(6):794-801. PubMed ID: 24861746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals.
    Hasan M; Siegmund W; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():193-199. PubMed ID: 27565568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode.
    Sugimoto H; Kakehi M; Satomi Y; Kamiguchi H; Jinno F
    J Sep Sci; 2015 Oct; 38(20):3516-24. PubMed ID: 26249017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
    Helmschrodt C; Becker S; Schröter J; Hecht M; Aust G; Thiery J; Ceglarek U
    Clin Chim Acta; 2013 Oct; 425():3-8. PubMed ID: 23827692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.
    Suzuki Y; Oda A; Negami J; Toyama D; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Lipid Res; 2022 Mar; 63(3):100184. PubMed ID: 35181316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
    Aubry AF; Dean B; Diczfalusy U; Goodenough A; Iffland A; McLeod J; Weng N; Yang Z
    AAPS J; 2016 Sep; 18(5):1056-1066. PubMed ID: 27350147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preanalytical standardization for reactive oxygen species derived oxysterol analysis in human plasma by liquid chromatography-tandem mass spectrometry.
    Helmschrodt C; Becker S; Thiery J; Ceglarek U
    Biochem Biophys Res Commun; 2014 Apr; 446(3):726-30. PubMed ID: 24370823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry.
    Pataj Z; Liebisch G; Schmitz G; Matysik S
    J Chromatogr A; 2016 Mar; 1439():82-88. PubMed ID: 26607314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS.
    Honda A; Yamashita K; Hara T; Ikegami T; Miyazaki T; Shirai M; Xu G; Numazawa M; Matsuzaki Y
    J Lipid Res; 2009 Feb; 50(2):350-7. PubMed ID: 18815436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
    Jemal M; Schuster A; Whigan DB
    Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
    Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
    AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
    Goodenough AK; Onorato JM; Ouyang Z; Chang S; Rodrigues AD; Kasichayanula S; Huang SP; Turley W; Burrell R; Bifano M; Jemal M; LaCreta F; Tymiak A; Wang-Iverson D
    Chem Res Toxicol; 2011 Sep; 24(9):1575-85. PubMed ID: 21728364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction.
    Xue YJ; Hoffmann M; Tong Z; Wu XI; Vallejo M; Melo B; Ye Y; Thomas M; Liu Y; Weiss D; Surapaneni S
    Bioanalysis; 2016 Feb; 8(3):215-28. PubMed ID: 26805594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry.
    Partani P; Modhave Y; Gurule S; Khuroo A; Monif T
    J Pharm Biomed Anal; 2009 Dec; 50(5):966-76. PubMed ID: 19640669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
    Li K; Zhao S; Zhang L; Wu X; Shu P; Wang Y; Feng H; Gu Z; Han Hsu H
    Drug Metab Dispos; 2014 May; 42(5):839-43. PubMed ID: 24595680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of total plasma oxysterols by enzymatic hydrolysis, solid phase extraction and liquid chromatography coupled to mass-spectrometry.
    Mendiara I; Domeño C; Nerín C; Geurts AM; Osada J; Martínez-Beamonte R
    J Pharm Biomed Anal; 2018 Feb; 150():396-405. PubMed ID: 29288965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of remifentanil with liquid chromatography-tandem mass spectrometry and an extensive stability investigation in EDTA whole blood and acidified EDTA plasma.
    Koster RA; Vereecke HE; Greijdanus B; Touw DJ; Struys MM; Alffenaar JW
    Anesth Analg; 2015 Jun; 120(6):1235-41. PubMed ID: 25692453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.